Fundraising FoxBoehringer Ingelheim Venture Fund — 2019 Investments
1 investments dated 2019 · listed companies and verified rows first · show all
Dopavisiondopavision.comJun 2019
Dopavision develops digital therapeutics that use selective ocular light stimulation delivered through consumer electronics to non-invasively activate the eye's signaling pathways.
Digital HealthHealthtechMedical Devices
Co-investorsSeventure Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.